These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4315663)

  • 41. [Dynamics of the formation of different components of the toxin of Cl. perfringens type A].
    Ispolatovskaia MV; Larina IA; Loseva LP
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Sep; 42(9):110-4. PubMed ID: 4288944
    [No Abstract]   [Full Text] [Related]  

  • 42. Degradation of arginine by Slackia exigua ATCC 700122 and Cryptobacterium curtum ATCC 700683.
    Uematsu H; Sato N; Djais A; Hoshino E
    Oral Microbiol Immunol; 2006 Dec; 21(6):381-4. PubMed ID: 17064396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lecithinase activity of mutant and wild strains of Clostridium perfringens.
    Schulze JA; Nakamura M
    Appl Microbiol; 1968 Oct; 16(10):1619-20. PubMed ID: 4300899
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibiotic-induced expression of a cryptic cpb2 gene in equine beta2-toxigenic Clostridium perfringens.
    Vilei EM; Schlatter Y; Perreten V; Straub R; Popoff MR; Gibert M; Gröne A; Frey J
    Mol Microbiol; 2005 Sep; 57(6):1570-81. PubMed ID: 16135225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Separation of lecithinase and collagenase activities of Cl. perfringens toxin by starch electrophoresis].
    ISPOLATOVSKAIA MV; LEVDIKOVA GA; LARINA Ia
    Biokhimiia; 1961; 26():77-81. PubMed ID: 13718051
    [No Abstract]   [Full Text] [Related]  

  • 46. [Study of the leukotoxic action of Clostridium perfringens type A toxin on the phagocytic activity of blood neutrophils taking into consideration the leukocytic reaction].
    Golovatiuk AL
    Mikrobiol Zh; 1973; 35(5):596-600. PubMed ID: 4361316
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies on rabbits and sheep concerning the immunogenic effect of various types of prepared toxins of Clostridium welchii (perfringens) type A with and without complete Freund's adjuvant].
    Katsaras K; Hartwigk H
    Zentralbl Veterinarmed B; 1973 Sep; 20(7):547-57. PubMed ID: 4358501
    [No Abstract]   [Full Text] [Related]  

  • 48. Increased formation of arginine deiminase by Clostridium perfringens FD-1 growing in the presence of caffeine.
    Sacks LE
    Experientia; 1985 Nov; 41(11):1435-7. PubMed ID: 2866109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Myocardial ultrastructure of a rabbit in the course of poisoning with the toxin of Clostridium perfringens type A].
    Arambasić M; Orescanin B
    Acta Med Iugosl; 1971; 25(3):257-66. PubMed ID: 4332400
    [No Abstract]   [Full Text] [Related]  

  • 50. [Factors causing the restoration of toxic properties in centrifugates of Cl. perfringens cultures which lost their toxicity].
    Zanchevskaia TA
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Sep; 42(9):115-20. PubMed ID: 4288945
    [No Abstract]   [Full Text] [Related]  

  • 51. Implication of Clostridium difficile and Clostridium perfringens iota toxins in experimental lincomycin-associated colitis of rabbits.
    Rehg JE; Pakes SP
    Lab Anim Sci; 1982 Jun; 32(3):253-7. PubMed ID: 6285077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Toxins and anatoxins of Clostridium perfringens].
    Cherkas GP; Kalinichenko MF; Biriukova SV; Podgornaia LG
    Mikrobiol Zh; 1971; 33(2):173-5. PubMed ID: 4326475
    [No Abstract]   [Full Text] [Related]  

  • 53. [On various toxigenic properties of Cl. perfringens types D and E].
    Marasanova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):147. PubMed ID: 4306878
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pathogenicity of various toxinogenic types of Clostridium perfringens administered by mouth to axenic and holoxenic mice].
    Hudault S; Bridonneau C; Raibaud P
    Ann Microbiol (Paris); 1983; 134B(2):277-83. PubMed ID: 6316828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular biology: no exception to reversibility.
    Zhang Y
    Nature; 2004 Oct; 431(7009):637-9. PubMed ID: 15470410
    [No Abstract]   [Full Text] [Related]  

  • 56. Immobilization and treatment of Streptococcus faecalis for the continuous conversion of arginine into citrulline.
    Cottenceau G; Dherbomez M; Lubochinsky B; Lettellier F
    Enzyme Microb Technol; 1990 May; 12(5):355-60. PubMed ID: 1367441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of electrocardiography in experimental intoxication with Clostridium perfringens A toxin].
    ORESCANIN B; ANTIC R; ISVANESKI M
    Acta Med Iugosl; 1960; 14():433-45. PubMed ID: 13731136
    [No Abstract]   [Full Text] [Related]  

  • 58. [The ultrastructure of toxigenic and non-toxigenic strains of Cl. tetani].
    Pavlova IB; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Apr; 46(4):12-5. PubMed ID: 4892761
    [No Abstract]   [Full Text] [Related]  

  • 59. The arginine dihydrolase system of Streptococcus faecalis. II. Properties of arginine desimidase.
    OGINSKY EL; GEHRIG RF
    J Biol Chem; 1952 Oct; 198(2):799-805. PubMed ID: 12999797
    [No Abstract]   [Full Text] [Related]  

  • 60. [Morphological and toxigenic properties of the S- and R- form of Cl. histolyticum. II. Toxigenic properties of the S- and R- variants of Cl. histolyticum].
    Kazdobina IS
    Zh Mikrobiol Epidemiol Immunobiol; 1965 May; 42(5):126-30. PubMed ID: 5887544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.